Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Evaxion Biotech Q1 EPS $0.03 Beats $(0.56) Estimate, Sales $51.00K Beat $37.00K Estimate

Author: Benzinga Newsdesk | May 28, 2024 08:30am

Evaxion Biotech (NASDAQ:EVAX) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.56) by 105.36 percent. This is a 112.5 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $51.00 thousand which beat the analyst consensus estimate of $37.00 thousand by 37.84 percent.

Posted In: EVAX